Results 11 to 20 of about 24,612,904 (297)

Neuropeptide Y receptors: How to get subtype selectivity [PDF]

open access: yesFrontiers in Endocrinology, 2013
The neuropeptide Y system is a multireceptor/multiligand system consisting of four receptors in humans (hY1, hY2, hY4, hY5) and three agonists (NPY, PYY, PP) that activate these receptors with different potency.
Xavier ePedragosa Badia   +2 more
doaj   +4 more sources

Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures

open access: yesNeurobiology of Disease, 2012
We recently demonstrated that recombinant adeno-associated viral vector-induced hippocampal overexpression of neuropeptide Y receptor, Y2, exerts a seizure-suppressant effect in kindling and kainate-induced models of epilepsy in rats.
Casper R. Gøtzsche   +8 more
doaj   +4 more sources

Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells. [PDF]

open access: yesPLoS ONE, 2013
Sympathetic nervous system (SNS) signalling regulates murine hepatic fibrogenesis through effects on hepatic stellate cells (HSC), and obesity-related hypertension with SNS activation accelerates progression of non-alcoholic fatty liver disease (NAFLD ...
Barbara Sigala   +11 more
doaj   +3 more sources

Evolution of neuropeptide Y/RFamide-like receptors in nematodes

open access: yesHeliyon
The Neuropeptide Y/RFamide-like receptors belong to the Rhodopsin-like G protein-coupled receptors G protein-coupled receptors (GPCRs) and are involved in functions such as locomotion, feeding and reproduction.
Franziska Reinhardt   +3 more
doaj   +2 more sources

New antagonist agents of neuropeptide y receptors [PDF]

open access: yesQuímica Nova, 2000
In the CNS, NPY has been implicated in obesity and feeding, endocrine function and metabolism. Potent and selective rNPY antagonists will be able to probe the merits of this approach for the treatment of obesity.
Ignacio Aldana   +8 more
doaj   +5 more sources

Neuropeptide Y—Graphene Oxide Complexes Inhibit Amygdala NPY‐Receptor Expressing Glutamatergic Pathways and Selectively Remove Aversive Memory In Vivo [PDF]

open access: yesAdvanced Science
Therapeutic needs to modulate brain circuits highlight graphene‐based materials (GBMs) as an emerging tool to engineer specific interventions to treat neuro‐diseases.
Elisa Pati   +10 more
doaj   +2 more sources

Effects of neuropeptide Y on electrical activity and myocardial contractility

open access: yesУчёные записки Казанского университета: Серия Естественные науки, 2018
Neuropeptide Y (NPY) and agonist Leu(31)Pro(34)NPY were used to determine the type of NPY receptors involved in electrical activity and myocardial contraction.
A.A. Zverev   +6 more
doaj   +1 more source

Development of neuropeptide Y-ergic innervation of the small intestine in rats

open access: yesУчёные записки Казанского университета: Серия Естественные науки, 2018
Neuropeptide Y (NPY) acts as a neurotransmitter in the autonomic nervous system, including in the metasympathetic intramural ganglia of the intestine.
P.M. Masliukov   +3 more
doaj   +1 more source

Neuropeptide Y receptors: a promising target for cancer imaging and therapy. [PDF]

open access: yesRegen Biomater, 2015
Neuropeptide Y (NPY) was first identified from porcine brain in 1982, and plays its biological functions in humans through NPY receptors (Y1, Y2, Y4 and Y5).
Li J, Tian Y, Wu A.
europepmc   +2 more sources

Empowering exhausted T cells of Glioblastoma patients by Neurotransmitters and Neuropeptides: decreasing immune checkpoint inhibitors, and increasing CD3zeta, proliferation and Glioblastoma arrest [PDF]

open access: yesCancer Immunology, Immunotherapy
Background Glioblastoma is the most common malignant brain tumor, with extremely poor prognosis, and patient’s T cells are exhausted, dysfunctional, and unable to eliminate Glioblastoma.
Mia Levite   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy